Shield Therapeutics (STX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

2.65p
   
  • Change Today:
    -0.050p
  • 52 Week High: 5.34
  • 52 Week Low: 1.23
  • Currency: UK Pounds
  • Shares Issued: 1,041.69m
  • Volume: 1,743,657
  • Market Cap: £27.60m
  • Beta: 0.10

Latest Deals

Traded Action Notifier PriceAmountValue
13-Feb-25 Buy Anders Lundstrom 3.70p 575,000 £21,275.00

Largest Deals (365 days)

Traded Action Notifier PriceAmountValue
13-Feb-25 Buy Anders Lundstrom 3.70p 575,000 £21,275.00

Director Shareholdings

Notifier Holding Value*
Hans-Peter Hasler 5,500,000 £145,750
Anders Lundstrom 575,000 £15,238

Major Shareholders

Notifier** Holding Value*
AOP Orphan Pharmaceuticals AG 158,070,394 £4,188,865
Nutrition-Wellness Venture SA 56,008,541 £1,484,226
Jupiter Fund Management plc 34,127,697 £904,384
Premier Miton Group PLC 30,000,000 £795,000
MaRu AG 12,532,918 £332,122
JPMorgan Asset Management Holdings Inc. 6,238,846 £165,329
Universities Superannuation Scheme Ltd 5,067,985 £134,302
Spreadex Ltd 4,123,006 £109,260

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

STX Market Data

Currency UK Pounds
Share Price 2.65p
Change Today -0.050p
% Change -1.85 %
52 Week High 5.34
52 Week Low 1.23
Volume 1,743,657
Shares Issued 1,041.69m
Market Cap £27.60m
Beta 0.10

STX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
40.27% below the market average40.27% below the market average40.27% below the market average40.27% below the market average40.27% below the market average
79.17% above the sector average79.17% above the sector average79.17% above the sector average79.17% above the sector average79.17% above the sector average
Price Trend
18.61% below the market average18.61% below the market average18.61% below the market average18.61% below the market average18.61% below the market average
6.12% above the sector average6.12% above the sector average6.12% above the sector average6.12% above the sector average6.12% above the sector average
Income Not Available
Growth
63.71% above the market average63.71% above the market average63.71% above the market average63.71% above the market average63.71% above the market average
74.19% above the sector average74.19% above the sector average74.19% above the sector average74.19% above the sector average74.19% above the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 2
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

STX Dividends

No dividends found

Trades for 07-Apr-2025

Time Volume / Share Price
13:05 114 @ 2.70p
13:05 60 @ 2.60p
13:05 156,093 @ 2.69p
12:47 264,150 @ 2.65p
11:43 10,535 @ 2.53p

STX Key Personnel

CEO Anders Lundstrom

Top of Page